Infinity Pharmaceuticals Inc (OTC Pink - Limited Information:INFIQ)
| 0.0037 Delayed Data As of Dec 01 |  -0.00007 / -1.88%Today’s Change | 0.00 Today|||52-Week Range 0.77 | -99.34% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $299.5K |
Company Description
Infinity Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing novel medicines for people with cancer. It focuses on its drug development segment. The company was founded by Steven H. Holtzman and Matthew D. Shair on March 22, 1995 and is headquartered in Cambridge, MA.
Contact Information
Infinity Pharmaceuticals, Inc. 1100 Massachusetts Avenue Cambridge Massachusetts 02138 |
Employees
Shareholders
| Individual stakeholders | 22.57% |
| Mutual fund holders | 0.62% |
| Other institutional | 0.21% |
Top Executives
| Seth A. Tasker | Chief Executive Officer |
| Jennifer Roberts | Vice President-Clinical Operations |
| Melissa Hackel | Vice President-Finance |
